Miyazaki, Japan

Katsuya Okazaki

This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Kogyo K.k.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuya Okazaki. Retrieved from https://idiyas.com/inventor/katsuya-okazaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsuya Okazaki: Innovator in Pyridine Derivatives

Introduction

Katsuya Okazaki is a notable inventor based in Miyazaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyridine derivatives. His innovative approach has led to advancements in psychotropic medicaments.

Latest Patents

Katsuya Okazaki holds 1 patent for his invention related to novel pyridine derivatives and 1,2,3,4-tetrahydropyridine derivatives. This invention is characterized by a general formula that includes various functional groups, making it useful in the development of psychotropic medications.

Career Highlights

Okazaki is associated with Asahi Kasei Kogyo K.K., where he has been able to apply his expertise in chemistry to develop new pharmaceutical compounds. His work has been instrumental in advancing the understanding and application of pyridine derivatives in medicine.

Collaborations

Throughout his career, Katsuya Okazaki has collaborated with notable colleagues, including Showa Ueki and Hiromu Kawakubo. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Katsuya Okazaki's contributions to the field of medicinal chemistry, particularly through his work on pyridine derivatives, highlight his role as an influential inventor. His ongoing efforts continue to impact the development of psychotropic medicaments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…